Cargando…

Liver X Receptor: A Novel Therapeutic Target

The liver X receptors α and β are orphan nuclear receptors that are key regulators in maintaining cholesterol homeostasis. Originally they were found to play an important role in reverse cholesterol transport, a pathway for the removal of excess cellular cholesterol. However several groups have now...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, M. B., Oza, N. A., Anand, I. S., Deshpande, S. S., Patel, C. N.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792482/ https://www.ncbi.nlm.nih.gov/pubmed/20046702 http://dx.doi.org/10.4103/0250-474X.41445

Ejemplares similares

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
por: Girisa, Sosmitha, et al.
Publicado: (2021)

Ligands of Therapeutic Utility for the Liver X Receptors
por: Komati, Rajesh, et al.
Publicado: (2017)

The P2X1 receptor as a therapeutic target
por: Bennetts, Felix M., et al.
Publicado: (2022)

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
por: Kim, Sun-Gi, et al.
Publicado: (2016)

Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
por: Kim, Hyejin, et al.
Publicado: (2023)

Emerging Insights into Liver X Receptor α in the Tumorigenesis and Therapeutics of Human Cancers
por: Han, Ning, et al.
Publicado: (2023)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
por: Bertolini, Anna, et al.
Publicado: (2022)

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
por: Petrescu, Anca D., et al.
Publicado: (2021)

Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
por: Gangwar, Shailendra Kumar, et al.
Publicado: (2022)

Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
por: Oishi, Naoki, et al.
Publicado: (2011)

Liver X Receptors and Male (In)fertility
por: Jarvis, Sheba, et al.
Publicado: (2019)

Liver X receptors and fat cell metabolism
por: Laurencikiene, J, et al.
Publicado: (2012)

The Serotonin-6 Receptor as a Novel Therapeutic Target
por: Yun, Hyung-Mun, et al.
Publicado: (2011)

Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy
por: Buckinx, An, et al.
Publicado: (2021)

Heart failure: Novel therapeutic approaches
por: Patel, C, et al.
Publicado: (2015)

The Role of the P2X7 Receptor in Ocular Stresses: A Potential Therapeutic Target
por: Dutot, Mélody, et al.
Publicado: (2017)

Identification of Novel Liver X Receptor Activators by Structure-Based Modeling
por: von Grafenstein, Susanne, et al.
Publicado: (2012)

Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology
por: Aryapour, Elham, et al.
Publicado: (2022)

Novel Therapeutic Approaches to Liver Fibrosis Based on Targeting Oxidative Stress
por: Blas-García, Ana, et al.
Publicado: (2023)

Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity
por: Eskandari, Mahsa, et al.
Publicado: (2022)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

The CB(2) Receptor as a Novel Therapeutic Target for Epilepsy Treatment
por: Ji, Xiaoyu, et al.
Publicado: (2021)

Novel clinical therapeutics targeting the epithelial to mesenchymal transition
por: Kothari, Anai N, et al.
Publicado: (2014)

Epilepsy: Novel therapeutic targets
por: Anovadiya, Ashish P., et al.
Publicado: (2012)

Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?
por: Grässel, Susanne, et al.
Publicado: (2018)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders
por: Jones, Daniel P., et al.
Publicado: (2018)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Extracellular zinc and ATP-gated P2X receptor calcium entry channels: New zinc receptors as physiological sensors and therapeutic targets
por: Schwiebert, Erik M., et al.
Publicado: (2005)

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials
por: Pithadia, Anand B., et al.
Publicado: (2009)

The Aryl Hydrocarbon Receptor (AHR): A Novel Therapeutic Target for Pulmonary Diseases?
por: Shivanna, Binoy, et al.
Publicado: (2022)

Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
por: Holanda, Victor A. D., et al.
Publicado: (2021)

Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
por: Wang, Hua, et al.
Publicado: (2011)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
por: Kessoku, Takaomi, et al.
Publicado: (2021)

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis
por: Mulligan, Jennifer K., et al.
Publicado: (2018)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
por: Ahmad, Fahim, et al.
Publicado: (2019)

The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
por: Burnstock, Geoffrey, et al.
Publicado: (2017)

The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
por: Kim, Dong-Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kor8macfvvv09719fc2rnljhde